已收盘 08-14 16:00:00 美东时间
-0.940
-3.15%
BTIG analyst Nick Altmann maintains Braze (NASDAQ:BRZE) with a Buy and raises the price target from $30 to $35.
08-14 19:34
Anavex Life Sciences Corp. filed definitive proxy materials with the SEC ahead of its 2026 Annual Meeting, urging stockholders to vote "FOR" its six independent director nominees on the WHITE proxy card. The company highlighted its strategy to enhance long-term value, including advancing oral blarcamesine across three CNS indications (early Alzheimer's disease, Rett syndrome, and Fragile X syndrome) and refreshing the Board with two new independe...
08-11 12:00
In its Q2 portfolio update, Next Century Growth Investors disclosed nine new positions across three sectors. The industrial additions were Park Aerospace Corp. (PKE), IPG Photonics Corporation (IPGP),...
07-24 23:00
This week saw minimal trades by insider executive. Major transactions were seen at firms including Morgan Stanley (MS) and Broadcom (AVGO). The following is a list of major trades that occurred betwee...
07-18 23:03
今日重点评级关注:Roth Capital:维持Nuvectis Pharma"买入"评级,目标价从20美元升至33美元;摩根士丹利:维持GXO Logistics"超配"评级,目标价从75美元升至78美元
07-07 11:34
JP Morgan analyst Alexei Gogolev maintains Braze (NASDAQ:BRZE) with a Overweight and raises the price target from $33 to $35.
07-06 20:50
Braze ( ($BRZE) ) has shared an announcement. On June 30, 2026, Braze held its ...
07-03 05:19
高盛认为人工智能将催生软件行业新领军企业,将Twilio(TWLO)、Braze(BRZE)、Klaviyo(KVYO)列为AI时代首选软件标的,全部给予“买入...
06-30 22:29
与半导体相关联的AI算力产业链已进入高波动、杠杆与看涨仓位极度拥挤、高预期兑现压力阶段,这种市场结构一定程度上有利于受益于AI应用超级大浪潮且与算力链同样身披“AI光环”的软件股大反攻行情。
06-29 15:56